Table 3.
Major outcome results.
Endpoint | Solid tumor malignancies N = 38 |
Hematologic malignancies N = 5 |
Total N = 43 |
---|---|---|---|
Incidence of major bleeding events, n (%) | 8 (21) | 1 (20) | 9 (20.9) |
Intracranial hemorrahage | 7 (18.4) | 1 (20) | 8 (18.6) |
Incidence of minor bleeding events, n (%) | 1 (2.6) | 1 (20) | 2 (4.6) |
Incidence of VTE during hospitalization, n (%) | 0 (0) | 0 (0) | 0 (0) |
NCCU length of stay, median in days (IQR) | 4 (1.25–17.75) | 5 (5–8.5) | 5 (2–12) |
Hospital length of stay, median in days (IQR) | 23.5 (11.75–60.5) | 9 (7.5–35.5) | 17 (10–62) |
30-day mortality, n (%) | 4 (10.5) | 2 (40) | 6 (13.9) |